Luis A. Martínez

Dr. Luis A. Martínez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
CGCristina García García
Cristina García García
LMLucrecia Moreno
Lucrecia Moreno
MAMónica Alacreu
Mónica Alacreu
Francisco Javier Muñoz-AlmarazFrancisco Javier Muñoz-Almaraz
Francisco Javier Muñoz-Almaraz
LMLuis A. Martínez
Luis A. Martínez
Cognitive impairment (CI), an intermediate phase between the decline in physiological cognition and dementia, is known to be mediated by a variety of risk and protective factors, with age being the most influential of these. The multifactorial nature of CI and the worldwide phenomenon of an aging population makes decoupling old age from disease through the concept of healthy aging (HA) a matter of major interest. Focusing on psychosocial variables and psychological constructs, here we designed and piloted a data collection booklet (DeCo-B) to assess CI and HA from a holistic perspective. The DeCo-B comprises six sections: sociodemographic factors, CI, meaning in life, psychosocial factors, health problems, and lifestyle. The estimated prevalence of CI and HA in our cohort were 24.4% and 6.6%, respectively. Spearman correlations mainly identified pairwise associations between the meaning in life domains and psychosocial variables. Moreover, age, marital status, purpose in life, resilience, chronic pain, cognitive reserve, and obstructive sleep apnea were significantly associated with an increased risk of CI. Our results showed that DeCo-B is a suitable tool for researching how modifiable risk and protective factors influence cognitive status. The complex interrelationships between variables should be further investigated and, for practical reasons, the questionnaire should be optimized in future work.

8 November 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
LSLucía Sáez-González
Lucía Sáez-González
MDMarcos Carreño Díaz
Marcos Carreño Díaz
GAGemma Blázquez Abellán
Gemma Blázquez Abellán
MSManuel Santander
Manuel Santander
RMRosa M. Martínez
Rosa M. Martínez
LCLucia Castro
Lucia Castro
Driven by a growing global interest in natural products, macroalgae have emerged as a prime source for nutraceuticals and pharmaceutical applications. In the current research, the effect of oven-drying (OD) and freeze-drying (FD), as well as the pressurized liquid extraction (PLE) conditions, were investigated in relation to the polyphenols, flavonoids, carotenoids, chlorophylls, and tocochromanols levels in Cladophora glomerata extracts. The ethanol–water extracts (1:1) obtained with PLE-150 °C from macroalgae oven-dried (OD)-80 °C displayed the highest total polyphenol content (TPC) and total flavonoid contents (TFCs), reaching 29.62 mg GAE/g and 5.92 mg QE/g. Aqueous extracts using PLE-200 °C were also an excellent environmentally friendly option for TPC and TFC isolation, which were the main factors accounting for the ABTS, DPPH, and FRAP antioxidant activity of the extracts. The remarkable effects of drying conditions positively affect the carotenoids, chlorophyll α-tocopherol, and α-tocotrienol levels from extracts showing 1.3–6 times higher amounts in extracts of Cladophora glomerata OD at 80 °C compared with other research approaches. Nanotechnology approaches allowed the formulation of antioxidant-loaded nanoemulsions from Cladophora glomerata extracts, providing stability and a great internalization rate that ameliorates to 85% the ROS levels, attenuating the oxidative stress induced by H2O2 in J774.1 macrophage cell line.

26 September 2023 in Pharmacy
Verified
Journal Article
Open access
PDF file
LMLuis A. Martínez
Luis A. Martínez
CGCristina García
Cristina García
LMLucrecia Moreno
Lucrecia Moreno
The increasing pressure on healthcare systems (HCSs) is a cause for concern worldwide. Rising costs, uncertainty about sustainability, and aging populations are the main issues that make it challenging to allocate scarce resources to the needs of HCSs. Clinical professional pharmacy services (PSs) have been shown to help alleviate system stress and to reach the entire population, although a cost of provision is borne. The objective of this study was to evaluate the provision costs of three PSs, a medicine-dispensing service (MDS), a multicompartmental compliance aid system service (MCAS), and a cognitive impairment screening service (CISS), in a rural community pharmacy. A cost analysis was performed using a time-driven activity-based costing model. The time dedicated to PS provision was appropriately recorded, and the corresponding expenses were extracted from the accounting records. A provision time of 4.80 min and a cost of EUR 2.24 were estimated for the MDS, while 18.33 min and EUR 8.73 were calculated for the MCAS, and 122.20 min and EUR 56.72 were calculated for the CISS. The total provision time represented 85% of the pharmacist’s effective working time. Tailored cost analysis is a useful tool for making decisions on the implementation of a PS. Larger studies including a variety of pharmacies and locations are necessary to accurately assess costs and engage in discussions on funding and remuneration.

27 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CGCristina García García
Cristina García García
JOJosé M. Ocaña
José M. Ocaña
MAMónica Alacreu
Mónica Alacreu
LMLucrecia Moreno
Lucrecia Moreno
LMLuis A. Martínez
Luis A. Martínez
Background: Frailty and polymedication are closely interrelated. Addressing these concurrent conditions in primary care settings relies on the utilization of potentially inappropriate medication (PIM) lists and medication reviews (MRs), particularly in rural areas, where healthcare professionals serve as the sole point of access to the medical system. The aim of this study was to examine the relationship between medication appropriateness and variables related to frailty in a rural municipality in order to propose potential strategies for therapy optimization. Methods: This cross-sectional study included all adult community dwellers aged 50 and above officially registered in the municipality of Tiriez (Albacete, Spain) in 2023 (n = 241). The primary outcome variable was frailty (assessed using the fatigue, resistance, ambulation, illness, and loss of weight (FRAIL) scale). The independent variables were age, gender, medication regimen, history of falls, comorbidities, PIMs (evaluated using the screening tool of older persons’ prescriptions (STOPP) 2023 criteria), fall-risk-increasing drugs (FRID), and anticholinergic burden (ACB). Results: The prevalence of frailty was approximately 20%. FRID and ACB scores were statistically associated (p-value < 0.001) with frailty, 1.1 ± 1.3 vs. 2.5 ± 1.7, and 1.0 ± 1.3 vs. 2.8 ± 2.5, respectively. Regardless of age, frailty was observed to be more prevalent among females (odds ratio (OR) [95% confidence interval (CI)]: 3.5 [1.5, 9.0]). On average, 2.1 ± 1.6 STOPP criteria were fulfilled, with the prolonged use of anxiolytics and anti-peptic-ulcer agents being the most frequent. Priority interventions (PIs) included opioid dose reduction, benzodiazepine withdrawal, and the assessment of antidepressant and antiplatelet treatment plans. Conclusions: The optimization of medication in primary care is of paramount importance for frail patients. Interventional measures should focus on ensuring the correct dosage and combination of drugs for each therapeutic regimen.

28 March 2023 in Farmacéuticos Comunitarios
Verified
Journal Article
Open access
LMLuis A. Martínez
Luis A. Martínez
CGC García
C García
LML Moreno
L Moreno
Introduction: Cognitive impairment is known to be mediated by a variety of risk factors, with age being the most influential of these. The worldwide phenomenon of an aging population makes decoupling old age from disease through the concept of healthy aging a matter of major interest. In Spain, rural depopulated areas, where the lack of health services is an additional concern, constitute a group of particularly aged population. Community pharmacies are widely distributed throughout the territory and are in close contact with this vulnerable population group. Methods: We designed and piloted a methodology to assess cognitive impairment and healthy aging from a holistic point of view. Our questionnaire comprises five sections: cognitive impairment, sociodemographic factors, health problems, lifestyle and psychosocial factors. Results: The estimated prevalences of cognitive impairment and healthy aging in our cohort were 28.2 % and 15.4 %, respectively. The prevalences (or the population mean values) found for well-known risk and protective factors for cognitive impairment were consistent with those described for Spanish population in the scientific literature. The results showed that our questionnaire can be an appropriate tool for collecting information in our media and suitable for researching how modifiable risk and protective factors influence cognitive status from a holistic perspective. Conclusion: The complex interrelationships between variables should be further investigated. In this respect, novel areas, such as psychosocial variables, should also be the focus of efforts to advance the cognitive impairment knowledge.

13 October 2020 in Farmacéuticos Comunitarios
Verified
Journal Article
Open access
LMLuis A. Martínez
Luis A. Martínez
JLJosé A. Carbajal de Lara
José A. Carbajal de Lara